Search
XTalPi Reaches AI Drug Discovery Collaboration with International Pharmaceutical Company Worth Over US$400 Million
1 day ago /
Read about 0 minute
Author：小编
On June 10, XTalPi announced a strategic collaboration worth over US$400 million with an internationally renowned biopharmaceutical company boasting multiple commercialized products, focusing on AI drug discovery. The two parties will jointly develop innovative oral small-molecule drugs targeting GPCR with 'best-in-class' potential. The collaborator will pay an upfront fee and cover early R&D expenses, while XTalPi will also receive preclinical, clinical, and commercial milestone payments, as well as sales royalties.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
